Blood Donor Day 2023: Experts weigh in
Drug Discovery World
JUNE 14, 2023
BCA members also operate the BCA Advanced Therapies Network which is a diverse, fully integrated portfolio of blood, cell, gene and tissue materials that support the development and delivery of advanced therapies. One example we are following with anticipation are the two FDA approvals for the first gene therapies for sickle cell disease.
52 
Let's personalize your content